THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 127 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $23,110,000 | – | 1,000,000 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 4,929,423 | $36,478,000 | 8.08% |
| Chescapmanager LLC | 1,892,452 | $14,004,000 | 1.98% |
| Baupost Group | 13,660,168 | $101,085,000 | 0.93% |
| Camber Capital Management LP | 2,500,000 | $18,500,000 | 0.57% |
| CM Management, LLC | 100,000 | $740,000 | 0.55% |
| Orbimed Advisors | 5,895,159 | $43,624,000 | 0.48% |
| Clearline Capital LP | 577,800 | $4,276,000 | 0.40% |
| Tri Locum Partners LP | 129,192 | $956,000 | 0.38% |
| Woodline Partners LP | 1,979,130 | $14,646,000 | 0.24% |
| Newtyn Management, LLC | 97,955 | $725,000 | 0.19% |